Prelude Capital Management’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-162,461
Closed -$5.59M 2421
2014
Q4
$5.59M Buy
162,461
+160,461
+8,023% +$5.23M 0.82% 14
2014
Q3
$60K Sell
2,000
-4,200
-68% -$89K 0.01% 1332
2014
Q2
$124K Buy
6,200
+4,500
+265% +$103K 0.02% 1011
2014
Q1
$46K Buy
+1,700
New +$45.1K 0.01% 1340
2013
Q4
Sell
-14,562
Closed -$265K 2182
2013
Q3
$265K Buy
+14,562
New +$263K 0.04% 453

Other funds holding AUXL

Prelude Capital Management's AUXL Position: Q1 2015 in Review

Prelude Capital Management sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 162,461 shares — an estimated $5.59M sold.

Prelude Capital Management first reported a position in AUXL in Q3 2013 and held it in 5 quarters. The position peaked at $5.59M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Prelude Capital Management reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Prelude Capital Management sold 162,461 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $5.59M.
  • Prelude Capital Management first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q3 2013 and held it in 5 quarters.
  • Prelude Capital Management's AUXILIUM PHARAMCEUTICALS INC position peaked at $5.59M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Prelude Capital Management's 13F filing for Q1 2015, filed 15 May 2015.